(Circulation. 2000;102:2694.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
Endovascular Brachytherapy for Prophylaxis of Restenosis After Femoropopliteal Angioplasty
Results of a Prospective Randomized Study
From the Department of Angiology (E.M., T.M., R.A., R.W.), the Department of Radiotherapy and Radiobiology (B.P., C.F., W.S., R.P.), and the Department of Medical Computer Sciences (M.M.), University of Vienna, General Hospital Vienna, Vienna, Austria.
Correspondence to Prof Erich Minar, Department of Angiology, University of Vienna, General Hospital Vienna, A-1097 Vienna, Austria. E-mail erich.minar{at}akh-wien.ac.at
Background—Inasmuch as endovascular brachytherapy (BT) has gained recent interest because of its inhibitory effect on mechanisms leading to restenosis after percutaneous transluminal angioplasty (PTA), we performed this randomized study to determine its efficacy for prophylaxis of restenosis after femoropopliteal PTA.
Methods and Results—One
hundred thirteen patients (63 men, 50 women; mean age 71 years) with de
novo or recurrent femoropopliteal lesions were included in this
randomized trial comparing the restenosis rate after PTA plus BT (57
patients, PTA+BT group) versus PTA (56 patients, PTA group) without
stent implantation. The mean treated length was 16.7 cm (PTA+BT group)
versus 14.8 cm (PTA group). In patients randomized to PTA plus BT, a
dose of 12 Gy was applied by an 192Ir source
3 mm from the source axis. Follow-up examinations included measurement
of the ankle-brachial index, color-flow duplex sonography, and
angiography. The primary end point of the study was patency after 6
months. The overall recurrence rate after 6 months was 15 (28.3%) of
53 in the PTA+BT group versus 29 (53.7%) of 54 in the PTA group
(
2 test, P<0.05). The
cumulative patency rates at 12 months of follow-up were 63.6% in the
PTA+BT group and 35.3% in the PTA group (log-rank test,
P<0.005).
Conclusions—This is the first randomized study to demonstrate the efficacy of endovascular BT for prophylaxis of restenosis after femoropopliteal PTA. The value of this approach should now be improved by modification of the BT procedure and by combination with stent implantation.
Key Words: peripheral vascular disease • angioplasty • restenosis • radioisotopes
This article has been cited by other articles:
 |
|
 |
|
  M. Werk, S. Langner, B. Reinkensmeier, H.-F. Boettcher, G. Tepe, U. Dietz, N. Hosten, B. Hamm, U. Speck, and J. Ricke Inhibition of Restenosis in Femoropopliteal Arteries: Paclitaxel-Coated Versus Uncoated Balloon: Femoral Paclitaxel Randomized Pilot Trial Circulation, September 23, 2008; 118(13): 1358 - 1365. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Tepe, T. Zeller, T. Albrecht, S. Heller, U. Schwarzwalder, J.-P. Beregi, M.D. C. D. Claussen, A. Oldenburg, B. Scheller, and U. Speck Local Delivery of Paclitaxel to Inhibit Restenosis during Angioplasty of the Leg N. Engl. J. Med., February 14, 2008; 358(7): 689 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Zeller Current state of endovascular treatment of femoro-popliteal artery disease Vascular Medicine, August 1, 2007; 12(3): 223 - 234. [Abstract] [PDF]
|
|
|
|
 |
|
 N. Diehm, I. Baumgartner, M. Jaff, D.-D. Do, E. Minar, J. Schmidli, C. Diehm, G. Biamino, F. Vermassen, D. Scheinert, et al. A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries Eur. Heart J., April 1, 2007; 28(7): 798 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Klonaris, A. Katsargyris, A. Giannopoulos, and E. Bastounis Advances in Endovascular Treatment of Femoropopliteal Arterial Occlusive Disease Perspectives in Vascular Surgery and Endovascular Therapy, December 1, 2006; 18(4): 329 - 341. [Abstract] [PDF]
|
|
|
|
 |
|
 R. M. Wolfram, A. C. Budinsky, B. Pokrajac, R. Potter, and E. Minar Endovascular Brachytherapy for Prophylaxis of Restenosis after Femoropopliteal Angioplasty: Five-year Follow-up--Prospective Randomized Study Radiology, September 1, 2006; 240(3): 878 - 884. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. J. Yacyshyn, M. R. Thatipelli, R. J. Lennon, K. R. Bailey, A. W. Stanson, D. R. Holmes Jr, and P. Gloviczki Predictors of Failure of Endovascular Therapy for Peripheral Arterial Disease Angiology, August 1, 2006; 57(4): 403 - 417. [Abstract] [PDF]
|
|
|
|
|
|
M. Schillinger, S. Sabeti, C. Loewe, P. Dick, J. Amighi, W. Mlekusch, O. Schlager, M. Cejna, J. Lammer, and E. Minar Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N. Engl. J. Med., May 4, 2006; 354(18): 1879 - 1888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Wolfram, A. C. Budinsky, B. Pokrajac, R. Potter, and E. Minar Vascular Brachytherapy with 192Ir after Femoropopliteal Stent Implantation in High-Risk Patients: Twelve-month Follow-up Results from the Vienna-5 Trial Radiology, July 1, 2005; 236(1): 343 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Wolfram, A. C. Budinsky, B. Pokrajac, R. Potter, and E. Minar Endovascular Brachytherapy: Restenosis in de Novo versus Recurrent Lesions of Femoropopliteal Artery--The Vienna Experience Radiology, July 1, 2005; 236(1): 338 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Therasse, D. Donath, J. Lesperance, J.-C. Tardif, M.-C. Guertin, V. L. Oliva, and G. Soulez External Beam Radiation to Prevent Restenosis After Superficial Femoral Artery Balloon Angioplasty Circulation, June 21, 2005; 111(24): 3310 - 3315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Goshima and J. L. Mills Sr De Novo Femoropopliteal stenoses: Endovascular Gamma Irradiation Following Angioplasty-Angiographic and Clinical Follow-up in a Prospective Randomized Controlled Trial Perspectives in Vascular Surgery and Endovascular Therapy, March 1, 2005; 17(1): 69 - 70. [Abstract] [PDF]
|
|
|
|
|
|
E. Minar, M. Schillinger, K. Krueger, and K. Lackner Endovascular Irradiation after Femoropopliteal Angioplasty * Drs Krueger and Lackner respond: Radiology, December 1, 2004; 233(3): 935 - 937. [Full Text] [PDF]
|
|
|
|
|
|
S. Sabeti, M. Schillinger, J. Amighi, C. Sherif, W. Mlekusch, R. Ahmadi, and E. Minar Primary Patency of Femoropopliteal Arteries Treated with Nitinol versus Stainless Steel Self-expanding Stents: Propensity Score-adjusted Analysis Radiology, August 1, 2004; 232(2): 516 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Krueger, M. Zaehringer, M. Bendel, H. Stuetzer, D. Strohe, M. Nolte, D. Wittig, R.-P. Mueller, and K. Lackner De Novo Femoropopliteal Stenoses: Endovascular Gamma Irradiation Following Angioplasty--Angiographic and Clinical Follow-up in a Prospective Randomized Controlled Trial Radiology, May 1, 2004; 231(2): 546 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Schillinger, M. Exner, E. Minar, W. Mlekusch, M. Mullner, C. Mannhalter, F. H. Bach, and O. Wagner Heme oxygenase-1 genotype and restenosis after balloon angioplasty: a novel vascular protective factor J. Am. Coll. Cardiol., March 17, 2004; 43(6): 950 - 957. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schillinger, W. Mlekusch, R. M. Wolfram, A. C. Budinsky, M. Exner, H. Rumpold, O. Wagner, B. Pokrajac, R. Potter, and E. Minar Endovascular Brachytherapy: Effect on Acute Inflammatory Response after Percutaneous Femoropopliteal Arterial Interventions Radiology, February 1, 2004; 230(2): 556 - 560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Teirstein and S. King Vascular Radiation in a Drug-Eluting Stent World: It's Not Over Till It's Over Circulation, July 29, 2003; 108(4): 384 - 385. [Full Text] [PDF]
|
|
|
|
|
|
R. Waksman and J. Weinberger Coronary Brachytherapy in the Drug-Eluting Stent Era: Don't Bury It Alive Circulation, July 29, 2003; 108(4): 386 - 388. [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Pearce and J. F. McKinsey Current Status of Intravascular Stents as Delivery Devices to Prevent Restenosis Vascular and Endovascular Surgery, July 1, 2003; 37(4): 231 - 237. [Abstract] [PDF]
|
|
|
|
|
|
M. Schillinger, M. Exner, W. Mlekusch, M. Haumer, H. Rumpold, R. Ahmadi, S. Sabeti, O. Wagner, and E. Minar Endovascular Revascularization Below the Knee: 6-month Results and Predictive Value of C-reactive Protein Level Radiology, May 1, 2003; 227(2): 419 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Bonvini, I. Baumgartner, D. D. Do, M. Alerci, J.-M. Segatto, P. Tutta, K. Jager, M. Aschwanden, E. Schneider, B. Amann-Vesti, et al. Late acute thrombotic occlusion after endovascular brachytherapy and stenting of femoropopliteal arteries J. Am. Coll. Cardiol., February 5, 2003; 41(3): 409 - 412. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schillinger, M. Exner, W. Mlekusch, H. Rumpold, R. Ahmadi, S. Sabeti, M. Haumer, O. Wagner, and E. Minar Vascular Inflammation and Percutaneous Transluminal Angioplasty of the Femoropopliteal Artery: Association with Restenosis Radiology, October 1, 2002; 225(1): 21 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. McCowan and M. L. Baker Brachytherapy: Hot or Not Radiology, August 1, 2002; 224(2): 323 - 324. [Full Text] [PDF]
|
|
|
|
|
|
K. Krueger, P. Landwehr, M. Bendel, M. Nolte, H. Stuetzer, R. Bongartz, M. Zaehringer, G. Winnekendonk, A. Gossmann, R.-P. Mueller, et al. Endovascular Gamma Irradiation of Femoropopliteal de Novo Stenoses Immediately after PTA: Interim Results of Prospective Randomized Controlled Trial Radiology, August 1, 2002; 224(2): 519 - 528. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Mozes and P. Gloviczki Adjuvant Therapy in Lower Extremity Revascularization: Prevention of Early and Intermediate Failures Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 2002; 15(2): 161 - 180. [Abstract] [PDF]
|
|
|
|
|
|
P. S. Teirstein and R. E. Kuntz New Frontiers in Interventional Cardiology: Intravascular Radiation to Prevent Restenosis Circulation, November 20, 2001; 104(21): 2620 - 2626. [Full Text] [PDF]
|
|
|
|
|
|
R. M. Wolfram, B. Pokrajac, R. Ahmadi, C. Fellner, M. Gyongyosi, M. Haumer, R. Bucek, R. Potter, and E. Minar Endovascular Brachytherapy for Prophylaxis against Restenosis after Long-Segment Femoropopliteal Placement of Stents: Initial Results Radiology, September 1, 2001; 220(3): 724 - 729. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Isner, P. R. Vale, J. F. Symes, and D. W. Losordo Assessment of Risks Associated With Cardiovascular Gene Therapy in Human Subjects Circ. Res., August 31, 2001; 89(5): 389 - 400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W. Losordo and J. M. Isner Vascular endothelial growth factor-induced angiogenesis: crouching tiger or hidden dragon? J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2131 - 2135. [Full Text] [PDF]
|
|
|
|
|
|
P. S. Teirstein Fulfilling the Promise of Percutaneous Angioplasty Circulation, November 28, 2000; 102(22): 2674 - 2676. [Full Text] [PDF]
|
|